Longitudinal Relationship between Cerebral Small-Vessel Disease and Cerebral Blood Flow

Stroke

Volumn 46, Issue 5, 2015, Pages 1233-1238

  Van Der Veen, Pieternella H ^a   Muller, Majon ^a,c   Vincken, Koen L ^b   Hendrikse, Jeroen ^a   Mali, Willem P T M ^a   Van Der Graaf, Yolanda ^a   Geerlings, Mirjam I ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

atherosclerosis; cerebral small vessel disease; magnetic resonance imaging

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ADULT; AGE; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN SIZE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; WHITE MATTER; AGED; BRAIN CIRCULATION; CEREBRAL ARTERY DISEASE; LACUNAR STROKE; LONGITUDINAL STUDY; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE;

AGE FACTORS; AGED; CEREBRAL ARTERIAL DISEASES; CEREBRAL SMALL VESSEL DISEASES; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STROKE, LACUNAR; WHITE MATTER;

EID: 84933530781     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.008030     Document Type: Article

References (29)

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689-701. doi: 10.1016/S1474-4422(10)70104-6.
2. Petito CK, Olarte JP, Roberts B, Nowak TS Jr, Pulsinelli WA. Selective glial vulnerability following transient global ischemia in rat brain. J Neuropathol Exp Neurol. 1998;57:231-238.
3. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke. 1996;27:1641-1647.
4. Bastos-Leite AJ, Kuijer JP, Rombouts SA, Sanz-Arigita E, van Straaten EC, Gouw AA, et al. Cerebral blood flow by using pulsed arterial spinlabeling in elderly subjects with white matter hyperintensities. AJNR Am J Neuroradiol. 2008;29:1296-1301. doi: 10.3174/ajnr.A1091.
5. van Es AC, van der Grond J, ten Dam VH, de Craen AJ, Blauw GJ, Westendorp RG, et al; PROSPER Study Group. Associations between total cerebral blood flow and age related changes of the brain. PLoS One. 2010;5:e9825. doi: 10.1371/journal.pone.0009825.
6. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Vrooman HA, Hofman A, et al. Total cerebral blood flow and total brain perfusion in the general population: the Rotterdam Scan Study. J Cereb Blood Flow Metab. 2008;28:412-419. doi: 10.1038/sj.jcbfm.9600526.
7. Alosco ML, Brickman AM, Spitznagel MB, Garcia SL, Narkhede A, Griffith EY, et al. Cerebral perfusion is associated with white matter hyperintensities in older adults with heart failure. Congest Heart Fail. 2013;19:E29-E34. doi: 10.1111/chf.12025.
8. Brickman AM, Zahra A, Muraskin J, Steffener J, Holland CM, Habeck C, et al. Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res. 2009;172:117-120. doi: 10.1016/j.pscychresns.2008.11.006.
9. van den Boom R, Lesnik Oberstein SA, Spilt A, Behloul F, Ferrari MD, Haan J, et al. Cerebral hemodynamics and white matter hyperintensities in CADASIL. J Cereb Blood Flow Metab. 2003;23:599-604. doi: 10.1097/01.WCB.0000062341.61367.D3.
10. Nezu T, Yokota C, Uehara T, Yamauchi M, Fukushima K, Toyoda K, et al. Preserved acetazolamide reactivity in lacunar patients with severe white-matter lesions: 15O-labeled gas and H2O positron emission tomography studies. J Cereb Blood Flow Metab. 2012;32:844-850. doi: 10.1038/jcbfm.2011.190.
11. Geerlings MI, Appelman AP, Vincken KL, Algra A, Witkamp TD, Mali WP, et al; SMART Study Group. Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study. Atherosclerosis. 2010;210:130-136. doi: 10.1016/j. atherosclerosis.2009.10.039.
12. Appelman AP, van der Graaf Y, Vincken KL, Tiehuis AM, Witkamp TD, Mali WP, et al; SMART Study Group. Total cerebral blood flow, white matter lesions and brain atrophy: the SMART-MR study. J Cereb Blood Flow Metab. 2008;28:633-639. doi: 10.1038/sj.jcbfm.9600563.
13. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59:1087-1091. doi: 10.1016/j.jclinepi.2006.01.014.
14. DeCarli C, Murphy DG, Tranh M, Grady CL, Haxby JV, Gillette JA, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology. 1995;45:2077-2084.
15. Takahashi W, Takagi S, Ide M, Shohtsu A, Shinohara Y. Reduced cerebral glucose metabolism in subjects with incidental hyperintensities on magnetic resonance imaging. J Neurol Sci. 2000;176:21-27.
16. Meguro K, Hatazawa J, Yamaguchi T, Itoh M, Matsuzawa T, Ono S, et al. Cerebral circulation and oxygen metabolism associated with subclinical periventricular hyperintensity as shown by magnetic resonance imaging. Ann Neurol. 1990;28:378-383. doi: 10.1002/ana.410280313.
17. Tohgi H, Yonezawa H, Takahashi S, Sato N, Kato E, Kudo M, et al. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology. 1998;40:131-137.
18. Reed BR, Eberling JL, Mungas D, Weiner M, Kramer JH, Jagust WJ. Effects of white matter lesions and lacunes on cortical function. Arch Neurol. 2004;61:1545-1550. doi: 10.1001/archneur.61.10.1545.
19. Mochizuki Y, Oishi M, Takasu T. Cerebral blood flow in single and multiple lacunar infarctions. Stroke. 1997;28:1458-1460.
20. Faraci FM, Brian JE Jr. Nitric oxide and the cerebral circulation. Stroke. 1994;25:692-703.
21. Marstrand JR, Garde E, Rostrup E, Ring P, Rosenbaum S, Mortensen EL, et al. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke. 2002;33:972-976.
22. Sachdev P, Wen W, Shnier R, Brodaty H. Cerebral blood volume in T2-weighted white matter hyperintensities using exogenous contrast based perfusion MRI. J Neuropsychiatry Clin Neurosci. 2004;16:83-92.
23. DeCarli C, Fletcher E, Ramey V, Harvey D, Jagust WJ. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke. 2005;36:50-55. doi: 10.1161/01. STR.0000150668.58689.f2.
24. Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T, et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology. 2006;66:23-29. doi: 10.1212/01.wnl.0000191403.95453.6a.
25. Liem MK, Lesnik Oberstein SA, Haan J, Boom Rv, Ferrari MD, Buchem MA, et al. Cerebrovascular reactivity is a main determinant of white matter hyperintensity progression in CADASIL. AJNR Am J Neuroradiol. 2009;30:1244-1247. doi: 10.3174/ajnr.A1533.
26. Duschek S, Hadjamu M, Schandry R. Enhancement of cerebral blood flow and cognitive performance following pharmacological blood pressure elevation in chronic hypotension. Psychophysiology. 2007;44:145-153. doi: 10.1111/j.1469-8986.2006.00472.x.
27. Hajjar I, Rodgers K. Do angiotensin receptor blockers prevent Alzheimer's disease? Curr Opin Cardiol. 2013;28:417-425. doi: 10.1097/HCO.0b013e3283620745.
28. Ainslie PN, Cotter JD, George KP, Lucas S, Murrell C, Shave R, et al. Elevation in cerebral blood flow velocity with aerobic fitness throughout healthy human ageing. J Physiol. 2008;586:4005-4010. doi: 10.1113/jphysiol.2008.158279.
29. Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, et al. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke. 2008;39:1127-1133. doi: 10.1161/STROKEAHA.107.497438.